We are currently upgrading our website. Please bear with us if you are experiencing any loading issues.
The Voice of MedTech in Asia
APACMed China launched the DRG-based value assessment project in 2021 to identify key challenges faced by innovative medical technologies in the ongoing DRG reform of China. APACMed China set up a DRG working group to follow up with key policymakers, KoLs and HCPs in China to develop the first industry research report.
The report, in Chinese, provides an overview of the current landscape, its challenges, as well as key recommendations going forward. An abridged English report is also available.
APACMed provides a unifying voice for the medical devices and in-vitro diagnostics industry in Asia Pacific. Founded in 2014, APACMed strives to promote innovation and impact policy that advances healthcare access for patients.
© Asia Pacific Medical Technology Association Ltd. All rights reserved. Read Our Terms Of Use
